Sanofi (MEX:SNY N) FFO


MEX:SNY N Sanofi SA MEX:SNY N
77 GF Score
Price MXN747.00
GF Value MXN1,091.82
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Sanofi FFO?

FFO (Funds from operations) only applies to REITs.

MEX:SNY N
77GF Score
Sanofi SA MEX:SNY N
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sanofi (MEX:SNY N) Overvalued in 2026?

Based on GuruFocus' analysis, Sanofi stock appears to be undervalued. The current stock price of MXN747.00 is trading 31.6% below its estimated GF Value™ of MXN1,091.82. GuruFocus considers Sanofi to be Possible Value Trap.

Key valuation signals for MEX:SNY N:

  • FFO:
  • GF Value™: MXN1,091.82 vs. price of MXN747.00 (31.6% below fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the MEX:SNY N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sanofi Business Description

Address 46, Avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
77GF Score

Get the complete analysis for MEX:SNY N

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN747.00
Price
MXN1,091.82
GF Value